Possibly one of the announcements you’ve been eagerly awaiting this week!

We are pleased to announce our new Course addressing the implementation of

the ‘Falsified Medicines Directive’ (Directive 2011/62/EU)

A one-day non-residential course
Tackling a major public health and safety problem

Thursday 3rd October 2013
Venue: Burlington House, Royal Society of Chemistry, London W1

The ‘Falsified Medicines Directive’ is one of the most significant pieces of pharmaceutical legislation to arrive for many years! The urgent intention is to protect European patients from receiving falsified medicines.

If you are involved with the production of active substances you will need to take serious account of this new legislation and the various means by which its Articles have been, are being and will continue to be applied in the daily life of the global pharmaceutical industry.

In addition and not surprisingly there are many legal changes taking effect that impact on excipients, also to protect the public from falsified medicines.

Most EU companies, aiming to ensure compliance with the new law, face the prospect of carrying out a lot more international and European work. However, it is not just European companies that are affected. This EU legislation has major impacts on a substantial number of parties operating outside the ‘European Community’.

Companies and people involved in the distribution or other movement of pharmaceutical materials from one place to another or with the use of these materials to make intermediates or finished medicines face new requirements, which means activities to know about and actions to be taken.

Unless you are already sure that you understand fully the changes being required, you would be wise to book your place on our new Course. We plan to deliver up-to-date knowledge and understanding to delegates to help them and therefore their companies counteract the menace of falsified medicines.

Follow the links on our site to learn more about the Course and to make your booking. We look forward to meeting you and to sharing a lively programme with good sessions dealing with your questions.


The Course is expected to have a broad appeal. It should be of particular interest to many professionals in the pharmaceutical and chemical industries, and associated businesses:

  • Qualified Persons (QPs), QP trainees, Auditors, Engineers, Scientists, Technicians
    working in Production, Development, Control, Compliance and Regulatory / Registration
  • Pharmaceutical Assessors, GMP Inspectors, Scientific / Medical Writers
    working in Competent Authorities
  • Staff working in Import, Distribution and Sales Departments / Companies

with interests in

  • Preparation and Control of Active Substances
  • Selection, Risk Assessment and Control of Excipients
  • Qualification of Suppliers
  • Formulation and Pharmaceutical Development
  • Pharmaceutical Quality System
  • Regulatory / Registration Departments
  • Purchasing and Supply of Substances for Pharmaceutical Use, Intermediates and Finished Medicinal Products